Status:
COMPLETED
JC-virus (JCV) Epidemiology in Multiple Sclerosis (MS)
Lead Sponsor:
Biogen
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
Brief Summary
The objective of the study is to estimate the prevalence of anti-JCV antibodies in multiple sclerosis (MS) participants.
Detailed Description
This is a cross-sectional, multi-center, multi-national, epidemiological study to estimate the prevalence of anti-JCV antibody in MS participants. This study will provide an estimate of the prevalence...
Eligibility Criteria
Inclusion
- Key
- All candidates for this study must have the ability to understand the purpose of the study and provide signed and dated informed consent.
- All patients with a diagnosis of Multiple Sclerosis (MS) of any type, irrespective of their treatment, are eligible to participate once.
- Key
Exclusion
- None
- NOTE: Other protocol defined Inclusion/Exclusion criteria may apply.
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
7726 Patients enrolled
Trial Details
Trial ID
NCT01185717
Start Date
September 1 2010
End Date
June 1 2012
Last Update
June 2 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.